Home › NDC Lookup › RxCUI directory › RxCUI 1439823

Riociguat 1.5 MG Oral Tablet — RxCUI 1439823

RxNorm drug concept · Semantic clinical drug
RxCUI 1439823 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1439823
Official nameRiociguat 1.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped5
Package NDCs mapped17
Reported Medicaid activity (SDUD)6,299 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Riociguat: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Riociguat is used to treat two serious lung conditions that cause dangerously high blood pressure in the arteries going to your lungs. One is called CTEPH — where blood clots block...
  • You take it three times a day, roughly evenly spaced throughout the day. The good news is that food doesn't affect how well it's absorbed, so you can take it with or without a meal...
  • How do I take it — does it matter if I take it with food?
  • The most common ones are headache, dizziness, an upset stomach or heartburn, nausea, and diarrhea — most of these are related to how the drug relaxes blood vessels throughout your...
📖 Read our full Riociguat guide →

🕸️ Concept Web — How Riociguat 1.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Riociguat 1.5 MG Oral Tablet RxCUI 1439823

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Riociguat 1439816
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Adempas 1439889
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Riociguat Oral Tablet 1439820
    • Riociguat Oral Product 1439818
    • Riociguat Pill 1439819
    • Riociguat Oral Tablet [Adempas] 1439891
    • Adempas Oral Product 1439892
    • Adempas Pill 1439893
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Riociguat 1.5 MG SCDC · 1439822
  • Riociguat Oral Tablet SCDF · 1439820
  • Riociguat Oral Product SCDG · 1439818
  • Riociguat Pill SCDG · 1439819

Brand-Name Concepts

  • Riociguat 1.5 MG Oral Tablet [Adempas] SBD · 1439899
  • Riociguat 1.5 MG [Adempas] SBDC · 1439898
  • Riociguat Oral Tablet [Adempas] SBDF · 1439891
  • Adempas Oral Product SBDG · 1439892
  • Adempas Pill SBDG · 1439893
  • Adempas BN · 1439889

📦 FDA Products & Package NDCs

5 products · 17 package NDCs
17 package NDCs map to RxCUI 1439823 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50419-0250-01 90 TABLET, FILM COATED in 1 BOTTLE (50419-250-01) Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-10-08
50419-0250-03 2 BLISTER PACK in 1 PACKAGE (50419-250-03) / 21 TABLET, FIL... Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-10-08
50419-0250-71 90 TABLET, FILM COATED in 1 BOTTLE (50419-250-71) Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-10-08
50419-0250-91 9 TABLET, FILM COATED in 1 BOTTLE (50419-250-91) Adempas Bayer HealthCare Pharmaceuticals Inc. 2014-09-18
50419-0251-01 90 TABLET, FILM COATED in 1 BOTTLE (50419-251-01) Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-10-08
50419-0251-03 2 BLISTER PACK in 1 PACKAGE (50419-251-03) / 21 TABLET, FIL... Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-10-08
50419-0251-71 90 TABLET, FILM COATED in 1 BOTTLE (50419-251-71) Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-10-08
50419-0251-91 9 TABLET, FILM COATED in 1 BOTTLE (50419-251-91) Adempas Bayer HealthCare Pharmaceuticals Inc. 2014-09-18
50419-0252-01 90 TABLET, FILM COATED in 1 BOTTLE (50419-252-01) Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-12-08
50419-0252-03 2 BLISTER PACK in 1 PACKAGE (50419-252-03) / 21 TABLET, FIL... Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-10-08
50419-0252-91 9 TABLET, FILM COATED in 1 BOTTLE (50419-252-91) Adempas Bayer HealthCare Pharmaceuticals Inc. 2014-09-18
50419-0253-01 90 TABLET, FILM COATED in 1 BOTTLE (50419-253-01) Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-10-08
50419-0253-03 2 BLISTER PACK in 1 PACKAGE (50419-253-03) / 21 TABLET, FIL... Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-10-08
50419-0253-91 9 TABLET, FILM COATED in 1 BOTTLE (50419-253-91) Adempas Bayer HealthCare Pharmaceuticals Inc. 2014-09-18
50419-0254-01 90 TABLET, FILM COATED in 1 BOTTLE (50419-254-01) Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-10-08
50419-0254-03 2 BLISTER PACK in 1 PACKAGE (50419-254-03) / 21 TABLET, FIL... Adempas Bayer HealthCare Pharmaceuticals Inc. 2013-10-08
50419-0254-91 9 TABLET, FILM COATED in 1 BOTTLE (50419-254-91) Adempas Bayer HealthCare Pharmaceuticals Inc. 2014-09-18
Observed labelers: Bayer HealthCare Pharmaceuticals Inc. (17) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.